Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Virtual Congress 2020

Start date: 09 Oct 2020
End date: 10 Oct 2020

As a leading congress in precision medicine in oncology, MAP was established by key opinion leaders in the field. MAP 2020 offered the same top-tier scientific research and education, and industry engagement that congress attendees are accustomed to, in an all-new digital environment.

Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists wishing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient.

The name of the Congress was recently changed into Molecular Analysis for Precision Oncology to better reflect its aim of focusing on science, translational research, education and collaboration.

Attendees of the MAP 2020 Virtual Congress, learned how to integrate insights from tumour sample analysis into daily practice, how to seek and identify actionable mutations in patient DNA and how to provide the best possible personalised treatment.

The MAP Congress is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.